NasdaqGS - Nasdaq Real Time Price USD
Terns Pharmaceuticals, Inc. (TERN)
3.5400
+0.0300
+(0.85%)
At close: June 5 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-71,658
-70,016
-67,390
-49,109
-41,827
Investing Cash Flow
-18,448
-12,410
-37,987
-22,272
-119,696
Financing Cash Flow
164,063
163,995
41,951
167,095
134,393
End Cash Position
139,056
161,439
79,926
143,235
47,699
Income Tax Paid Supplemental Data
--
60
28
3
238
Capital Expenditure
--
-42
-52
-275
-340
Issuance of Capital Stock
--
162,312
41,611
167,253
136,362
Issuance of Debt
--
--
--
--
0
Repayment of Debt
--
--
--
0
-12,880
Free Cash Flow
-71,671
-70,058
-67,442
-49,384
-42,167
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GPCR Structure Therapeutics Inc.
21.47
-2.41%
ALT Altimmune, Inc.
5.46
-0.55%
PRTA Prothena Corporation plc
5.06
+3.69%
CRVS Corvus Pharmaceuticals, Inc.
3.9100
+4.27%
AKRO Akero Therapeutics, Inc.
53.94
+1.79%
RLAY Relay Therapeutics, Inc.
3.2400
+0.31%
MDGL Madrigal Pharmaceuticals, Inc.
274.10
-1.87%
ETNB 89bio, Inc.
9.96
-0.99%
JANX Janux Therapeutics, Inc.
24.76
-1.47%
MTSR Metsera, Inc.
28.67
+0.31%